Rapport Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Bredt David
Rapport Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Rapport Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Ignelzi Troy A.
Rapport Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Young Wendy B.
Rapport Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Rapport Therapeutics | 10-K: FY2024 Annual Report
Rapport Therapeutics | 8-K: Rapport Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
Rapport Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Gault Cheryl
Rapport Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Sevigny Jeffrey
Rapport Therapeutics | 8-K: Current report
Rapport Therapeutics | SCHEDULE 13G: Others
Rapport Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Ignelzi Troy A.
Rapport Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Yeleswaram Krishnaswamy
Rapport Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Bredt David
Rapport Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Ceesay Abraham
Rapport Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Gault Cheryl
Rapport Therapeutics | 8-K: Current report
Rapport Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-ARCH Venture Fund XII, L.P.(10.2%),ARCH Venture Partners XII, L.P.(10.2%), etc.
Rapport Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Cormorant Asset Management, LP(8.04%),Bihua Chen(8.04%)
Rapport Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Capital International Investors(7.1%)